Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMARCC2 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-07 |
mRNA | TXNDC16 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-07 |
mRNA | OSBPL5 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-07 |
mRNA | TSPAN32 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | LGALS9 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
mRNA | CCDC167 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-07 |
mRNA | CCDC28B | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-07 |
mRNA | TMSB15B | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
mRNA | SLX4 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-07 |